InterVest Co.
VC Fund
Seoul, South Korea
InterVest Co. is a VC fund in Seoul focused on Artificial Intelligence and Software. InterVest Co., Ltd. is a venture capital firm specializing in startups and early stage businesses and provide pre-initial public offering financing through mezzanine and bridge transactions. It typically invests in biotechnology, healthcare, semiconductor, display, metal and non-metal, energy, machinery, nanotechnology, telecommunications equipment and services, wireless communication terminal-related hardware, computer, software and applications and digital content sectors in Korea.
- Total investments:
- 149
- Last investment:
- Lead investor:
- 16%
- Fund size:
- $60M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries InterVest Co. invests in
Stages InterVest Co. invests in
Countries InterVest Co. invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $2.3M–$36M
- Series B
- $2.6M–$54M
- Series C
- $14M–$56M
Investment Focus
Industry
- Artificial Intelligence 29 (19%)
- Software 23 (15%)
- Information Technology 19 (13%)
- Health Care 15 (10%)
- Machine Learning 13 (9%)
Stage
- Series B 46 (31%)
- Series A 37 (25%)
- Series C 22 (15%)
- Seed 16 (11%)
- Venture - Series Unknown 11 (7%)
Country
- South Korea 91 (61%)
- United States 14 (9%)
- Singapore 2 (1%)
- India 1 (1%)
- Japan 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Chung-Hee Woo
Co-Founder, Chief Executive Officer & Member of the Board
|
Co-Founder, Chief Executive Officer & Member of the Board | Total investments: 1 | Find email | |
|
Sang Gyun Kim
Managing Director
|
Managing Director | Total investments: 1 | Find email | |
|
Simon Baek
Director
|
Director | Total investments: 2 | Find email | |
|
Tae-Yong Lee
Co-Founder & Chief Executive Officer
|
Co-Founder & Chief Executive Officer | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| MVRIX is a forward-thinking biotechnology company that focuses on pushing the boundaries of therapeutic innovation. The company specialises in developing new drugs based on platform technology related to membranes and viruses, enabling humans to be free from the attack of viruses and microorganisms. Additionally, it offers engineerable recombinantbotulinum toxin and virucidal therapeutics. | $5.9M / Series B / Sep 04, 2026 | ||
Inserasolution
|
Inserasolution produces high-performance Fast & Fine Steering Mirrors for laser-based space optical communications and sophisticated defense systems. | $9.8M / Series A / Sep 01, 2026 | |
| Quintessent is a Santa Barbara start-up that commercializes quantum dot-based lasers and photonic integrated circuits. Its solutions leverage the unique properties of quantum dot gain media with co-designed architectures to enable future applications in optical networking, deep learning systems, and sensing.It is based in Santa Barbara,California. | $40M / Series A / Aug 24, 2026 | ||
| Flexell Space engages in space solar cells, focusing on improving cost, delivery, design, and power efficiency. | $20M / Series A / Jul 14, 2026 | ||
| WIRobotics is a Wearable robot that lessen physical demands on your body to safely allow active motion. | $63.5M / Series B / May 15, 2026 | ||
| Upstage AI develops artificial intelligence technologies focused on large language models and document processing systems designed to support enterprise workflows. Its platform includes tools that convert unstructured data such as PDFs, scans, and emails into structured, machine-readable formats, enabling downstream analysis and automation. Thecompany also provides models like its Solar LLM, which are optimized for tasks such as text generation, information extraction, and question answering within business environments. Its solutions are applied across industries including finance, healthcare, insurance, and manufacturing to handle tasks like document parsing, data extraction, and workflow automation. Additionally, its services can be deployed through APIs, cloud environments, or on-premise systems to integrate with existing enterprise infrastructure. | $121.7M / Series C / Apr 15, 2026 | ||
| TelePIX is a leading global provider of high-resolution electro-optics payload solutions, serving the needs of earth observation, surveillance, and tracking applications.With a mission to extract and deliver space-derived insights to inspire and create value for all, TelePIX, a NewSpace Startup, engages in ventures encompassing ultrahigh-resolution multispectral EO/IR nanosatellites, satellite image big data analytics software and services, as well as ground station operations. | $10M / Venture - Series Unknown / Mar 16, 2026 | ||
| Vitestro transform patient care with autonomous blood drawing technology. | $70M / Series B / Mar 10, 2026 | ||
| Galux provides molecular design technology focusing on discovering and developing novel drugs for incurable and rare diseases using its AI-based drug design platform technologies. | $29M / Series B / Feb 09, 2026 | ||
| Coversummon seems to be working at the intersection of fashion, technology, and sustainability—an area with a lot of potential for innovation. | Venture - Series Unknown / Jan 08, 2026 | ||
| See all 149 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does InterVest Co. invest in?
InterVest Co. invests primarily in Artificial Intelligence, Software and Information Technology startups, most often at Series B and Series A stage. Most of the 149 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does InterVest Co. invest in?
InterVest Co. typically joins rounds of $2.3M–$36M at Series A, $2.6M–$54M at Series B and $14M–$56M at Series C. These are whole funding-round sizes, not InterVest Co.'s own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds InterVest Co. took part in.
How do I contact InterVest Co.?
Public channels for InterVest Co. include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at InterVest Co.?
The team at InterVest Co. includes Chung-Hee Woo (Co-Founder, Chief Executive Officer & Member of the Board), Sang Gyun Kim (Managing Director) and Simon Baek (Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
